Loading...
OTCM
XCRP
Market cap0kUSD
Mar 06, Last price  
0.00USD
Name

Xcorporeal Inc

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
0k
5,326,1921,613,3264,400,000460,98500000000
Net income
-23m
L+34.63%
-7,515,607-3,522,710-6,700,000-8,125,258-1,091,796-7,060,4901,210,517-4,227,435-671,9725,325,016-17,074,051-22,987,273
CFO
-13m
L+18.28%
-6,706,035-2,661,326-5,200,000-1,249,982-112,714-618,466-225,000-225,832-42,771-46,288-10,767,402-12,736,133

Profile

Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010. The company has formed the liquidating trust, Xcorporeal, Inc. Liquidating Trust, and transferred all of its assets to the trust for the purpose of completing the liquidation and dissolution of the company. Previously, it operated as a medical device company, which was engaged in the development of an extra-corporeal platform technology to be used in devices to replace the function of various human organs. Xcorporeal, Inc. was founded in 2001 and is based in Lake Forest, California.
URL
IPO date
Feb 29, 2000
Employees
Domiciled in
US
Incorporated in
US

Valuation

No data to show